about
The clinical efficacy of artemether/lumefantrine (Coartem)The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaUpdate on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjectsArtemether-lumefantrine: an option for malaria.Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic reviewIn vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.A prospective study of adverse drug reactions to artemisinin-based combination therapy in a tertiary care hospital in India.Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Coartem(®): a decade of patient-centric malaria management.Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers.Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.[Efficacy of artemether-lumefantrine in the treatment of uncomplicated malaria in children living in a rural area of Burkina Faso in 2009].Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis.Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
P2860
Q21034141-25202BA8-F184-49C0-924D-623E0E7B0B53Q28478579-0B039124-7947-4CD5-9110-6949D735CD2BQ33635019-3AA03828-BE3E-4BB0-9FF6-BDCE97E0AFE5Q34154423-9E326821-0B5E-427B-AA3C-6A948882F5AEQ34267667-8784C6D0-1F0D-4A35-AA4C-2B79DDF8C248Q34716441-5681874F-35B1-4BF0-8013-2C5B5C2A509EQ35004430-EDCAADF8-ADA4-43D8-B5CB-B0023F6FE928Q35029488-E33BE4EA-407E-46D2-942E-3F448B09C4B5Q35186075-5822D8D7-243C-4BBC-AA7B-B8E9993A1E32Q35692270-B45D3A16-2A03-4517-ACF6-2514C3ED20CDQ35890432-AD7ABB8E-8613-4DD1-AA40-BB68CB728F46Q36125279-FD2DD6AC-1203-4B15-9057-D73418D94B44Q37735182-A2F79E9C-E196-4472-86B1-422C354F1F12Q37857327-C321B0E1-8DE8-47F7-8076-5E86735A6AA3Q39042892-A02A8594-5F92-410F-8B0F-F2C33F4F181BQ39099424-1A9E70F0-EA44-4F46-9567-C1331A2B19F4Q39941785-4418364A-0E13-48B2-8A2F-BCC84451E9D0Q40296716-F59E9F03-CEE4-4D75-9316-B27EA65208EBQ41926058-46C3E595-971F-4F3A-8ED8-0DC2353B4803Q42712939-6E8C2F70-1AA0-4FA6-922F-34E620FA4D30Q47124275-7E1E7B2D-C270-432E-B86B-D053E006225EQ48022479-43839B60-78F4-42A9-A301-EB1D90E03A86
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety profile of Coartem: the evidence base.
@en
Safety profile of Coartem: the evidence base.
@nl
type
label
Safety profile of Coartem: the evidence base.
@en
Safety profile of Coartem: the evidence base.
@nl
prefLabel
Safety profile of Coartem: the evidence base.
@en
Safety profile of Coartem: the evidence base.
@nl
P2860
P921
P1433
P1476
Safety profile of Coartem: the evidence base.
@en
P2860
P2888
P356
10.1186/1475-2875-8-S1-S6
P478
P5008
P577
2009-10-12T00:00:00Z
P5875
P6179
1024496588